| Autor: |
Ghosh, Soumya, Al-Sharify, Zainab T., Maleka, Mathabatha Frank, Onyeaka, Helen, Maleke, Maleke, Maolloum, Alhaji, Godoy, Liliana, Meskini, Maryam, Rami, Mina Rezghi, Ahmadi, Shabnam, Al-Najjar, Shahad Z., Al-Sharify, Noor T., Ahmed, Sura M., Dehghani, Mohammad Hadi |
| Předmět: |
|
| Zdroj: |
Environmental Science & Pollution Research; Aug2022, Vol. 29 Issue 39, p58628-58647, 20p |
| Abstrakt: |
This current study review provides a brief review of a natural bee product known as propolis and its relevance toward combating SARS-CoV viruses. Propolis has been utilized in medicinal products for centuries due to its excellent biological properties. These include anti-oxidant, immunomodulatory, anti-inflammatory, anti-viral, anti-fungal, and bactericidal activities. Furthermore, studies on molecular simulations show that flavonoids in propolis may reduce viral replication. While further research is needed to validate this theory, it has been observed that COVID-19 patients receiving propolis show earlier viral clearance, enhanced symptom recovery, quicker discharge from hospitals, and a reduced mortality rate relative to other patients. As a result, it appears that propolis could probably be useful in the treatment of SARS-CoV-2-infected patients. Therefore, this review sought to explore the natural properties of propolis and further evaluated past studies that investigated propolis as an alternative product for the treatment of COVID-19 symptoms. In addition, the review also highlights the possible mode of propolis action as well as molecular simulations of propolis compounds that may interact with the SARS-CoV-2 virus. The activity of propolis compounds in decreasing the impact of COVID-19-related comorbidities, the possible roles of such compounds as COVID-19 vaccine adjuvants, and the use of nutraceuticals in COVID-19 treatment, instead of pharmaceuticals, has also been discussed. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink